---
figid: PMC10149982__gr7
figtitle: Spatiotemporally resolved metabolomics and isotope tracing reveal CNS drug
  targets
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC10149982
filename: gr7.jpg
figlink: /pmc/articles/PMC10149982/figure/fig7/
number: F7
caption: The potential targets of YZG-331. (A) YZG-331 increases GAD activity to promote
  GABA; (B) YZG-331 increases GABA, histamine and 1-methylhistamine levels in the
  rat brain; (C) YZG-331 may accelerate the inactivation of histamine via OCT3; The
  increased peripheral histamine permeates the pineal gland; (D) YZG-331 enhances
  intracellular histidine uptake and acts upon OCT3 to increase the outward transport
  of histamine in the periphery. Gln, glutamine; Glu, glutamate; GABA, γ-aminobutyric
  acid; His, histidine; HA, histamine; 1-methylHA, 1-methyl histamine; SA, succinic
  acid; TCA, tricarboxylic acid; GS, glutamine synthetase; PAG, phosphate-activated
  glutaminase; GAD, glutamic acid decarboxylase; HNMT, histamine N-methyltransferase;
  HDC, histidine decarboxylase; OCT3, organic cation transporter 3; PMAT, plasma membrane
  monoamine transporter; VMAT2, vesicular monoamine transporter 2; H1R, histamine
  H1 receptor; H2R, histamine H2 receptor; H3R, histamine H3 receptor. The histamine
  pathway in the brain has been illustrated according to a previous report.
papertitle: Spatiotemporally resolved metabolomics and isotope tracing reveal CNS
  drug targets.
reftext: Bo Jin, et al. Acta Pharm Sin B. 2023 Apr;13(4):1699-1710.
year: '2023'
doi: 10.1016/j.apsb.2022.11.011
journal_title: Acta Pharmaceutica Sinica. B
journal_nlm_ta: Acta Pharm Sin B
publisher_name: Elsevier
keywords: Ambient mass spectrometry imaging | Spatiotemporally resolved metabolomics
  | Isotope tracing | Drug targets | Central nervous system | Drug candidate
automl_pathway: 0.9232948
figid_alias: PMC10149982__F7
figtype: Figure
redirect_from: /figures/PMC10149982__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10149982__gr7.html
  '@type': Dataset
  description: The potential targets of YZG-331. (A) YZG-331 increases GAD activity
    to promote GABA; (B) YZG-331 increases GABA, histamine and 1-methylhistamine levels
    in the rat brain; (C) YZG-331 may accelerate the inactivation of histamine via
    OCT3; The increased peripheral histamine permeates the pineal gland; (D) YZG-331
    enhances intracellular histidine uptake and acts upon OCT3 to increase the outward
    transport of histamine in the periphery. Gln, glutamine; Glu, glutamate; GABA,
    γ-aminobutyric acid; His, histidine; HA, histamine; 1-methylHA, 1-methyl histamine;
    SA, succinic acid; TCA, tricarboxylic acid; GS, glutamine synthetase; PAG, phosphate-activated
    glutaminase; GAD, glutamic acid decarboxylase; HNMT, histamine N-methyltransferase;
    HDC, histidine decarboxylase; OCT3, organic cation transporter 3; PMAT, plasma
    membrane monoamine transporter; VMAT2, vesicular monoamine transporter 2; H1R,
    histamine H1 receptor; H2R, histamine H2 receptor; H3R, histamine H3 receptor.
    The histamine pathway in the brain has been illustrated according to a previous
    report.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - pag
  - GABA-B-R1
  - Rdl
  - Gabat
  - Gad1
  - gs
  - SA
  - sa
  - ha
  - Hdc
  - hdc
  - chb
  - PRDX1
  - PAG1
  - GAD1
  - GAD2
  - GNAS
  - GNAL
  - HDC
  - HECA
  - HRH2
  - POU5F1
  - SLC22A3
  - POU5F1P3
  - POU5F1P4
  - SLC29A4
  - SLC18A2
  - HNMT
  - HRH1
  - SPACA9
  - SPG21
  - Glu
  - GABA
  - Glu-TCA
  - Histaminergic
  - GS
---
